#USA #Needham #Evident #CrestOptics #Optical Imaging

Evident Completes Acquisition of CrestOptics S.p.A.

NEEDHAM, Mass., October 5, 2026 – Evident has officially announced the successful acquisition of CrestOptics S.p.A., a leading optical imaging company based in Rome. This strategic purchase is set to broaden Evident's portfolio in advanced imaging systems, particularly within the life sciences domain, enhancing their capabilities in high-speed, high-content 3D imaging solutions tailored for research, pharmaceutical, and biotechnology applications.

Background on CrestOptics

Founded in 2011, CrestOptics specializes in developing and manufacturing advanced optical imaging systems, focusing on confocal microscopy with spinning disk technology and super-resolution capabilities. Their innovative products include the X-Light series of spinning disk confocal systems, known for precise optical sectioning and uniform illumination across a top-tier field of view. Additionally, their compact CICERO solution merges wide-field and spinning disk methodologies, making high-quality confocal technology accessible to laboratories at a competitive entry-level. Another significant product is DeepSIM, which provides super-resolution imaging below the diffraction limit, combining performance with ease of use for various working environments.

CrestOptics' systems have been widely adopted in laboratories across the globe, designed to aid scientific discovery without barriers.

The Vision Behind the Acquisition

Wes Pringle, CEO of Evident, stated, “Researchers are posing increasingly complex questions regarding biological models that are also growing more intricate. This necessitates faster, less invasive, and higher-resolution imaging techniques. Our clients push the boundaries of science, and we aim to drive the optical technologies that make their discoveries faster and more accessible than ever. Evident and CrestOptics share a mutual vision, and through this collaboration, it became evident that their mission, engineering capabilities, and essential human resources align perfectly with ours, allowing us to deliver more comprehensive solutions for the scientists that rely on our support.”

The partnership between Evident and CrestOptics has existed for several years, with CrestOptics’ spinning disk technology already integrated into Evident’s current microscope configurations. This acquisition formalizes and extends that successful collaboration.

A Natural Progression for CrestOptics

Renato Giacobbo Scavo, CEO of CrestOptics, remarked, “Joining Evident is a natural next step for CrestOptics. We share a commitment to expanding the horizons of what microscopy can reveal. With Evident's extensive global reach, manufacturing capabilities, and application expertise, we will accelerate our innovation roadmap and bring our technologies to many more laboratories worldwide. We are grateful to our prior investors, Apposite Capital and Primo Capital, as well as to our Chairman, David Martyr, and the Board of Directors, for their support throughout this journey.”

CrestOptics will continue operations from its headquarters in Rome, which also houses their R&D and manufacturing facilities. They will maintain existing relationships with partners and distributors, continuing their vital role as a technological supplier to the microscopy sector.

About Evident

For over a century, Olympus has set the standard in optical precision for microscopy. Today, Evident carries on that legacy, aiding scientists, healthcare professionals, and engineers in visualizing the unseen through advanced imaging solutions that merge renowned optics with digital innovation. Evident offers an expansive life sciences portfolio that ranges from brightfield and darkfield microscopy to advanced fluorescence, 4D analytics, and digital pathology. In the industrial microscopy domain, the company provides laser scanning systems and digital solutions for semiconductor inspection, quality control, and manufacturing analysis. Evident is headquartered in Tokyo, with R&D and manufacturing centers in Japan, the USA, Germany, and China, along with sales and service operations globally. For additional information, visit EvidentScientific.com.

About CrestOptics

Established in 2011 in Rome, Italy, CrestOptics develops and manufactures advanced optical imaging systems for life sciences research. Their confocal spinning disk and super-resolution SIM technologies offer high-speed, high-contrast imaging with low phototoxicity, enabling research with live cells, 3D models, and thick tissues that conventional techniques cannot resolve. Their product range includes the X-Light family of spinning disk confocal systems, the integrated confocal solution CICERO, and the super-resolution module DeepSIM, all engineered for broad compatibility with leading microscopy platforms. CrestOptics also develops custom optical solutions for OEMs serving research, pharmaceutical, biotechnology, and industrial markets. The company operates R&D and manufacturing facilities in Rome certified with ISO 9001 and collaborates with research institutions, including the Italian Institute of Technology. For more information, visit CrestOptics.com.